Complicated Skin and Skin Structure Infections Drugs - Global and China Top Players Market Share and Ranking 2023
According to YH Research, the global market for Complicated Skin and Skin Structure Infections Drugs should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China's market share increased from percent to percent. China Complicated Skin and Skin Structure Infections Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Complicated Skin and Skin Structure Infections Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospital grew percent to account for percent of the total market sales, and Specialist Clinic grew percent.
Skin and skin structure infections are among the most common bacterial infection of skin-related tissues. The increased antimicrobial resistance among both gram-positive and gram-negative bacteria is a rapidly growing reason for hospitalization in complicated skin structural infections. Skin structural infections are usually considered complicated in case of needed surgery combined with antimicrobial therapy. The complicated skin structural infections generally include burns, ulcers, and major underlying diseases that complicate antibiotic treatment. The major symptoms of skin and skin structure infections include pus, blisters, skin sloughing, breakdown, and skin being discolored and painful.
This report studies and analyses global Complicated Skin and Skin Structure Infections Drugs status and future trends, helps the client to determine the Complicated Skin and Skin Structure Infections Drugs market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Complicated Skin and Skin Structure Infections Drugs, and provides market size (in Tons & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Complicated Skin and Skin Structure Infections Drugs market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (Tons)
(2) Global Complicated Skin and Skin Structure Infections Drugs sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Tons)
(3) China Complicated Skin and Skin Structure Infections Drugs sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Tons)
(4) Global Complicated Skin and Skin Structure Infections Drugs key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Complicated Skin and Skin Structure Infections Drugs key producing regions, capacity, production, and year over year growth
(6) Complicated Skin and Skin Structure Infections Drugs industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Novartis AG
Endo International Inc
Teva Pharmaceutical Industries Ltd
Glenmark Pharmaceuticals Ltd
Cipla Inc
Dr Reddy's Laboratories Ltd
Abbott
F. Hoffmann-La Roche Ltd
Pfizer Inc
Zydus Group
Lupin
Melinta Therapeutics, Inc
MerLion Pharmaceuticals GmbH
Paratek Pharmaceuticals, Inc
Market segment by Type, covers
Tedizolid
Vancomycin
Ceftaroline
Linezolid
Darbavansing
Olivanstar
Tedizolid
Market segment by Application, can be divided into
Hospital
Specialist Clinic
Home Care
Other
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Complicated Skin and Skin Structure Infections Drugs product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Complicated Skin and Skin Structure Infections Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Complicated Skin and Skin Structure Infections Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Complicated Skin and Skin Structure Infections Drugs, percent & CAGR, 2018-2029
Chapter 5: Complicated Skin and Skin Structure Infections Drugs industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Complicated Skin and Skin Structure Infections Drugs Definition
1.2 Global Complicated Skin and Skin Structure Infections Drugs Market Size and Forecast
1.2.1 By Consumption Value, Global Complicated Skin and Skin Structure Infections Drugs Market Size，2018-2029
1.2.2 By Sales Quantity, Global Complicated Skin and Skin Structure Infections Drugs Market Size，2018-2029
1.2.3 Global Complicated Skin and Skin Structure Infections Drugs Average Selling Price (ASP)，2018-2029
1.3 China Complicated Skin and Skin Structure Infections Drugs Market Size and Forecast
1.3.1 By Consumption Value, China Complicated Skin and Skin Structure Infections Drugs Market Size，2018-2029
1.3.2 By Sales Quantity, China Complicated Skin and Skin Structure Infections Drugs Market Size，2018-2029
1.3.3 China Complicated Skin and Skin Structure Infections Drugs Average Selling Price (ASP)， 2018-2029
1.4 Share of China Complicated Skin and Skin Structure Infections Drugs Market with Respect to the Global Market
1.4.1 By Consumption Value, China Complicated Skin and Skin Structure Infections Drugs Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Complicated Skin and Skin Structure Infections Drugs Market Share in Global, 2018-2029
1.4.3 Complicated Skin and Skin Structure Infections Drugs Market Size: China VS Global, 2018-2029
1.5 Complicated Skin and Skin Structure Infections Drugs Market Dynamics
1.5.1 Complicated Skin and Skin Structure Infections Drugs Market Drivers
1.5.2 Complicated Skin and Skin Structure Infections Drugs Market Restraints
1.5.3 Complicated Skin and Skin Structure Infections Drugs Industry Trends
1.5.4 Complicated Skin and Skin Structure Infections Drugs Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Complicated Skin and Skin Structure Infections Drugs, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Complicated Skin and Skin Structure Infections Drugs, Global Market Share by Company, 2018-2023
2.3 Complicated Skin and Skin Structure Infections Drugs Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Complicated Skin and Skin Structure Infections Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Complicated Skin and Skin Structure Infections Drugs Concentration Ratio
2.6 Global Complicated Skin and Skin Structure Infections Drugs Mergers & Acquisitions, Expansion Plans
2.7 Global Complicated Skin and Skin Structure Infections Drugs Manufacturers Product Type
2.8 Head Office and Complicated Skin and Skin Structure Infections Drugs Production Site of Key Manufacturer
2.9 Complicated Skin and Skin Structure Infections Drugs Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Complicated Skin and Skin Structure Infections Drugs, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Complicated Skin and Skin Structure Infections Drugs, China Market Share by Company, 2018-2023
3.3 China Complicated Skin and Skin Structure Infections Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Complicated Skin and Skin Structure Infections Drugs Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Complicated Skin and Skin Structure Infections Drugs Capacity by Region
4.3 Global Complicated Skin and Skin Structure Infections Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Complicated Skin and Skin Structure Infections Drugs Production by Region, 2018-2029
4.5 Global Complicated Skin and Skin Structure Infections Drugs Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Complicated Skin and Skin Structure Infections Drugs Industry Chain
5.2 Complicated Skin and Skin Structure Infections Drugs Upstream Analysis
5.2.1 Complicated Skin and Skin Structure Infections Drugs Core Raw Materials
5.2.2 Main Manufacturers of Complicated Skin and Skin Structure Infections Drugs Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Complicated Skin and Skin Structure Infections Drugs Production Mode
5.6 Complicated Skin and Skin Structure Infections Drugs Procurement Model
5.7 Complicated Skin and Skin Structure Infections Drugs Industry Sales Model and Sales Channels
5.7.1 Complicated Skin and Skin Structure Infections Drugs Sales Model
5.7.2 Complicated Skin and Skin Structure Infections Drugs Typical Distributors
6 Sights by Type
6.1 Complicated Skin and Skin Structure Infections Drugs Classification
6.1.1 Tedizolid
6.1.2 Vancomycin
6.1.3 Ceftaroline
6.1.4 Linezolid
6.1.5 Darbavansing
6.1.6 Olivanstar
6.1.7 Tedizolid
6.2 By Type, Global Complicated Skin and Skin Structure Infections Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Complicated Skin and Skin Structure Infections Drugs Consumption Value, 2018-2029
6.4 By Type, Global Complicated Skin and Skin Structure Infections Drugs Sales Quantity, 2018-2029
6.5 By Type, Global Complicated Skin and Skin Structure Infections Drugs Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Complicated Skin and Skin Structure Infections Drugs Segment by Application
7.1.1 Hospital
7.1.2 Specialist Clinic
7.1.3 Home Care
7.1.4 Other
7.2 By Application, Global Complicated Skin and Skin Structure Infections Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Complicated Skin and Skin Structure Infections Drugs Consumption Value, 2018-2029
7.4 By Application, Global Complicated Skin and Skin Structure Infections Drugs Sales Quantity, 2018-2029
7.5 By Application, Global Complicated Skin and Skin Structure Infections Drugs Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Complicated Skin and Skin Structure Infections Drugs Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Complicated Skin and Skin Structure Infections Drugs Consumption Value, 2018-2029
8.3 By Region, Global Complicated Skin and Skin Structure Infections Drugs Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Complicated Skin and Skin Structure Infections Drugs & Forecasts, 2018-2029
8.4.2 By Country, North America Complicated Skin and Skin Structure Infections Drugs Market Size Market Share
8.5 Europe
8.5.1 Europe Complicated Skin and Skin Structure Infections Drugs Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Complicated Skin and Skin Structure Infections Drugs Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Complicated Skin and Skin Structure Infections Drugs Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Complicated Skin and Skin Structure Infections Drugs Market Size Market Share
8.7 South America
8.7.1 South America Complicated Skin and Skin Structure Infections Drugs Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Complicated Skin and Skin Structure Infections Drugs Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Complicated Skin and Skin Structure Infections Drugs Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Complicated Skin and Skin Structure Infections Drugs Consumption Value, 2018-2029
9.3 By Country, Global Complicated Skin and Skin Structure Infections Drugs Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Complicated Skin and Skin Structure Infections Drugs Market Size, 2018-2029
9.4.2 By Type, U.S. Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Complicated Skin and Skin Structure Infections Drugs Market Size, 2018-2029
9.5.2 By Type, Europe Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Complicated Skin and Skin Structure Infections Drugs Market Size, 2018-2029
9.6.2 By Type, China Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Complicated Skin and Skin Structure Infections Drugs Market Size, 2018-2029
9.7.2 By Type, Japan Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Complicated Skin and Skin Structure Infections Drugs Market Size, 2018-2029
9.8.2 By Type, South Korea Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Complicated Skin and Skin Structure Infections Drugs Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Complicated Skin and Skin Structure Infections Drugs Market Size, 2018-2029
9.10.2 By Type, India Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Complicated Skin and Skin Structure Infections Drugs Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Novartis AG
10.1.1 Novartis AG Company Information, Head Office, Market Area, and Industry Position
10.1.2 Novartis AG Complicated Skin and Skin Structure Infections Drugs Models, Specifications, and Application
10.1.3 Novartis AG Complicated Skin and Skin Structure Infections Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Novartis AG Company Profile and Main Business
10.1.5 Novartis AG Recent Developments
10.2 Endo International Inc
10.2.1 Endo International Inc Company Information, Head Office, Market Area, and Industry Position
10.2.2 Endo International Inc Complicated Skin and Skin Structure Infections Drugs Models, Specifications, and Application
10.2.3 Endo International Inc Complicated Skin and Skin Structure Infections Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Endo International Inc Company Profile and Main Business
10.2.5 Endo International Inc Recent Developments
10.3 Teva Pharmaceutical Industries Ltd
10.3.1 Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area, and Industry Position
10.3.2 Teva Pharmaceutical Industries Ltd Complicated Skin and Skin Structure Infections Drugs Models, Specifications, and Application
10.3.3 Teva Pharmaceutical Industries Ltd Complicated Skin and Skin Structure Infections Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Teva Pharmaceutical Industries Ltd Company Profile and Main Business
10.3.5 Teva Pharmaceutical Industries Ltd Recent Developments
10.4 Glenmark Pharmaceuticals Ltd
10.4.1 Glenmark Pharmaceuticals Ltd Company Information, Head Office, Market Area, and Industry Position
10.4.2 Glenmark Pharmaceuticals Ltd Complicated Skin and Skin Structure Infections Drugs Models, Specifications, and Application
10.4.3 Glenmark Pharmaceuticals Ltd Complicated Skin and Skin Structure Infections Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Glenmark Pharmaceuticals Ltd Company Profile and Main Business
10.4.5 Glenmark Pharmaceuticals Ltd Recent Developments
10.5 Cipla Inc
10.5.1 Cipla Inc Company Information, Head Office, Market Area, and Industry Position
10.5.2 Cipla Inc Complicated Skin and Skin Structure Infections Drugs Models, Specifications, and Application
10.5.3 Cipla Inc Complicated Skin and Skin Structure Infections Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Cipla Inc Company Profile and Main Business
10.5.5 Cipla Inc Recent Developments
10.6 Dr Reddy's Laboratories Ltd
10.6.1 Dr Reddy's Laboratories Ltd Company Information, Head Office, Market Area, and Industry Position
10.6.2 Dr Reddy's Laboratories Ltd Complicated Skin and Skin Structure Infections Drugs Models, Specifications, and Application
10.6.3 Dr Reddy's Laboratories Ltd Complicated Skin and Skin Structure Infections Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Dr Reddy's Laboratories Ltd Company Profile and Main Business
10.6.5 Dr Reddy's Laboratories Ltd Recent Developments
10.7 Abbott
10.7.1 Abbott Company Information, Head Office, Market Area, and Industry Position
10.7.2 Abbott Complicated Skin and Skin Structure Infections Drugs Models, Specifications, and Application
10.7.3 Abbott Complicated Skin and Skin Structure Infections Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Abbott Company Profile and Main Business
10.7.5 Abbott Recent Developments
10.8 F. Hoffmann-La Roche Ltd
10.8.1 F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area, and Industry Position
10.8.2 F. Hoffmann-La Roche Ltd Complicated Skin and Skin Structure Infections Drugs Models, Specifications, and Application
10.8.3 F. Hoffmann-La Roche Ltd Complicated Skin and Skin Structure Infections Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 F. Hoffmann-La Roche Ltd Company Profile and Main Business
10.8.5 F. Hoffmann-La Roche Ltd Recent Developments
10.9 Pfizer Inc
10.9.1 Pfizer Inc Company Information, Head Office, Market Area, and Industry Position
10.9.2 Pfizer Inc Complicated Skin and Skin Structure Infections Drugs Models, Specifications, and Application
10.9.3 Pfizer Inc Complicated Skin and Skin Structure Infections Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Pfizer Inc Company Profile and Main Business
10.9.5 Pfizer Inc Recent Developments
10.10 Zydus Group
10.10.1 Zydus Group Company Information, Head Office, Market Area, and Industry Position
10.10.2 Zydus Group Complicated Skin and Skin Structure Infections Drugs Models, Specifications, and Application
10.10.3 Zydus Group Complicated Skin and Skin Structure Infections Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Zydus Group Company Profile and Main Business
10.10.5 Zydus Group Recent Developments
10.11 Lupin
10.11.1 Lupin Company Information, Head Office, Market Area, and Industry Position
10.11.2 Lupin Complicated Skin and Skin Structure Infections Drugs Models, Specifications, and Application
10.11.3 Lupin Complicated Skin and Skin Structure Infections Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Lupin Company Profile and Main Business
10.11.5 Lupin Recent Developments
10.12 Melinta Therapeutics, Inc
10.12.1 Melinta Therapeutics, Inc Company Information, Head Office, Market Area, and Industry Position
10.12.2 Melinta Therapeutics, Inc Complicated Skin and Skin Structure Infections Drugs Models, Specifications, and Application
10.12.3 Melinta Therapeutics, Inc Complicated Skin and Skin Structure Infections Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Melinta Therapeutics, Inc Company Profile and Main Business
10.12.5 Melinta Therapeutics, Inc Recent Developments
10.13 MerLion Pharmaceuticals GmbH
10.13.1 MerLion Pharmaceuticals GmbH Company Information, Head Office, Market Area, and Industry Position
10.13.2 MerLion Pharmaceuticals GmbH Complicated Skin and Skin Structure Infections Drugs Models, Specifications, and Application
10.13.3 MerLion Pharmaceuticals GmbH Complicated Skin and Skin Structure Infections Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 MerLion Pharmaceuticals GmbH Company Profile and Main Business
10.13.5 MerLion Pharmaceuticals GmbH Recent Developments
10.14 Paratek Pharmaceuticals, Inc
10.14.1 Paratek Pharmaceuticals, Inc Company Information, Head Office, Market Area, and Industry Position
10.14.2 Paratek Pharmaceuticals, Inc Complicated Skin and Skin Structure Infections Drugs Models, Specifications, and Application
10.14.3 Paratek Pharmaceuticals, Inc Complicated Skin and Skin Structure Infections Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Paratek Pharmaceuticals, Inc Company Profile and Main Business
10.14.5 Paratek Pharmaceuticals, Inc Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables and Figures
Table 1. Complicated Skin and Skin Structure Infections Drugs Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Complicated Skin and Skin Structure Infections Drugs Market Restraints
Table 3. Complicated Skin and Skin Structure Infections Drugs Market Trends
Table 4. Complicated Skin and Skin Structure Infections Drugs Industry Policy
Table 5. Global Complicated Skin and Skin Structure Infections Drugs Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Complicated Skin and Skin Structure Infections Drugs Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Complicated Skin and Skin Structure Infections Drugs Sales Quantity by Company, (2018-2023) & (Tons), Ranked Based on Sales in 2022
Table 8. Global Complicated Skin and Skin Structure Infections Drugs Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Complicated Skin and Skin Structure Infections Drugs Average Selling Price (ASP) by Company, (2018-2023) & (US$/Ton)
Table 10. Global Complicated Skin and Skin Structure Infections Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Complicated Skin and Skin Structure Infections Drugs Mergers & Acquisitions, Expansion Plans
Table 12. Global Complicated Skin and Skin Structure Infections Drugs Manufacturers Product Type
Table 13. Head Office and Complicated Skin and Skin Structure Infections Drugs Production Site of Key Manufacturer
Table 14. Complicated Skin and Skin Structure Infections Drugs Capacity of Major Manufacturers and Future Plan
Table 15. China Complicated Skin and Skin Structure Infections Drugs Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Complicated Skin and Skin Structure Infections Drugs Sales Quantity by Company, (2018-2023) & (Tons), Ranked Based on Sales in 2022
Table 17. China Complicated Skin and Skin Structure Infections Drugs Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Complicated Skin and Skin Structure Infections Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029, (Tons)
Table 19. Global Complicated Skin and Skin Structure Infections Drugs Production by Region, 2018-2023, (Tons)
Table 20. Global Complicated Skin and Skin Structure Infections Drugs Production Forecast by Region, 2024-2029, (Tons)
Table 21. Global Key Players of Complicated Skin and Skin Structure Infections Drugs Upstream (Raw Materials)
Table 22. Global Complicated Skin and Skin Structure Infections Drugs Typical Customers
Table 23. Complicated Skin and Skin Structure Infections Drugs Typical Distributors
Table 24. By Type, Global Complicated Skin and Skin Structure Infections Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Complicated Skin and Skin Structure Infections Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Complicated Skin and Skin Structure Infections Drugs Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Complicated Skin and Skin Structure Infections Drugs Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Complicated Skin and Skin Structure Infections Drugs Sales Quantity, 2018-2029, (Tons)
Table 29. By Country, Global Complicated Skin and Skin Structure Infections Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Complicated Skin and Skin Structure Infections Drugs Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Complicated Skin and Skin Structure Infections Drugs Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Complicated Skin and Skin Structure Infections Drugs Sales Quantity, 2018-2029, (Tons)
Table 33. By Country, Global Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2018-2029
Table 34. Novartis AG Company Information, Head Office, Market Area, and Industry Position
Table 35. Novartis AG Complicated Skin and Skin Structure Infections Drugs Models, Specifications, and Application
Table 36. Novartis AG Complicated Skin and Skin Structure Infections Drugs Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 37. Novartis AG Company Profile and Main Business
Table 38. Novartis AG Recent Developments
Table 39. Endo International Inc Company Information, Head Office, Market Area, and Industry Position
Table 40. Endo International Inc Complicated Skin and Skin Structure Infections Drugs Models, Specifications, and Application
Table 41. Endo International Inc Complicated Skin and Skin Structure Infections Drugs Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 42. Endo International Inc Company Profile and Main Business
Table 43. Endo International Inc Recent Developments
Table 44. Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area, and Industry Position
Table 45. Teva Pharmaceutical Industries Ltd Complicated Skin and Skin Structure Infections Drugs Models, Specifications, and Application
Table 46. Teva Pharmaceutical Industries Ltd Complicated Skin and Skin Structure Infections Drugs Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 47. Teva Pharmaceutical Industries Ltd Company Profile and Main Business
Table 48. Teva Pharmaceutical Industries Ltd Recent Developments
Table 49. Glenmark Pharmaceuticals Ltd Company Information, Head Office, Market Area, and Industry Position
Table 50. Glenmark Pharmaceuticals Ltd Complicated Skin and Skin Structure Infections Drugs Models, Specifications, and Application
Table 51. Glenmark Pharmaceuticals Ltd Complicated Skin and Skin Structure Infections Drugs Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 52. Glenmark Pharmaceuticals Ltd Company Profile and Main Business
Table 53. Glenmark Pharmaceuticals Ltd Recent Developments
Table 54. Cipla Inc Company Information, Head Office, Market Area, and Industry Position
Table 55. Cipla Inc Complicated Skin and Skin Structure Infections Drugs Models, Specifications, and Application
Table 56. Cipla Inc Complicated Skin and Skin Structure Infections Drugs Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 57. Cipla Inc Company Profile and Main Business
Table 58. Cipla Inc Recent Developments
Table 59. Dr Reddy's Laboratories Ltd Company Information, Head Office, Market Area, and Industry Position
Table 60. Dr Reddy's Laboratories Ltd Complicated Skin and Skin Structure Infections Drugs Models, Specifications, and Application
Table 61. Dr Reddy's Laboratories Ltd Complicated Skin and Skin Structure Infections Drugs Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 62. Dr Reddy's Laboratories Ltd Company Profile and Main Business
Table 63. Dr Reddy's Laboratories Ltd Recent Developments
Table 64. Abbott Company Information, Head Office, Market Area, and Industry Position
Table 65. Abbott Complicated Skin and Skin Structure Infections Drugs Models, Specifications, and Application
Table 66. Abbott Complicated Skin and Skin Structure Infections Drugs Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 67. Abbott Company Profile and Main Business
Table 68. Abbott Recent Developments
Table 69. F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area, and Industry Position
Table 70. F. Hoffmann-La Roche Ltd Complicated Skin and Skin Structure Infections Drugs Models, Specifications, and Application
Table 71. F. Hoffmann-La Roche Ltd Complicated Skin and Skin Structure Infections Drugs Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 72. F. Hoffmann-La Roche Ltd Company Profile and Main Business
Table 73. F. Hoffmann-La Roche Ltd Recent Developments
Table 74. Pfizer Inc Company Information, Head Office, Market Area, and Industry Position
Table 75. Pfizer Inc Complicated Skin and Skin Structure Infections Drugs Models, Specifications, and Application
Table 76. Pfizer Inc Complicated Skin and Skin Structure Infections Drugs Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 77. Pfizer Inc Company Profile and Main Business
Table 78. Pfizer Inc Recent Developments
Table 79. Zydus Group Company Information, Head Office, Market Area, and Industry Position
Table 80. Zydus Group Complicated Skin and Skin Structure Infections Drugs Models, Specifications, and Application
Table 81. Zydus Group Complicated Skin and Skin Structure Infections Drugs Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 82. Zydus Group Company Profile and Main Business
Table 83. Zydus Group Recent Developments
Table 84. Lupin Company Information, Head Office, Market Area, and Industry Position
Table 85. Lupin Complicated Skin and Skin Structure Infections Drugs Models, Specifications, and Application
Table 86. Lupin Complicated Skin and Skin Structure Infections Drugs Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 87. Lupin Company Profile and Main Business
Table 88. Lupin Recent Developments
Table 89. Melinta Therapeutics, Inc Company Information, Head Office, Market Area, and Industry Position
Table 90. Melinta Therapeutics, Inc Complicated Skin and Skin Structure Infections Drugs Models, Specifications, and Application
Table 91. Melinta Therapeutics, Inc Complicated Skin and Skin Structure Infections Drugs Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 92. Melinta Therapeutics, Inc Company Profile and Main Business
Table 93. Melinta Therapeutics, Inc Recent Developments
Table 94. MerLion Pharmaceuticals GmbH Company Information, Head Office, Market Area, and Industry Position
Table 95. MerLion Pharmaceuticals GmbH Complicated Skin and Skin Structure Infections Drugs Models, Specifications, and Application
Table 96. MerLion Pharmaceuticals GmbH Complicated Skin and Skin Structure Infections Drugs Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 97. MerLion Pharmaceuticals GmbH Company Profile and Main Business
Table 98. MerLion Pharmaceuticals GmbH Recent Developments
Table 99. Paratek Pharmaceuticals, Inc Company Information, Head Office, Market Area, and Industry Position
Table 100. Paratek Pharmaceuticals, Inc Complicated Skin and Skin Structure Infections Drugs Models, Specifications, and Application
Table 101. Paratek Pharmaceuticals, Inc Complicated Skin and Skin Structure Infections Drugs Sales Quantity (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin, 2018-2023
Table 102. Paratek Pharmaceuticals, Inc Company Profile and Main Business
Table 103. Paratek Pharmaceuticals, Inc Recent Developments
List of Figures
Figure 1. Complicated Skin and Skin Structure Infections Drugs Picture
Figure 2. Global Complicated Skin and Skin Structure Infections Drugs Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Complicated Skin and Skin Structure Infections Drugs Sales Quantity, (Tons) & (2018-2029)
Figure 4. Global Complicated Skin and Skin Structure Infections Drugs Average Selling Price (ASP), (2018-2029) & (US$/Ton)
Figure 5. China Complicated Skin and Skin Structure Infections Drugs Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Complicated Skin and Skin Structure Infections Drugs Sales Quantity (Tons) & (2018-2029)
Figure 7. China Complicated Skin and Skin Structure Infections Drugs Average Selling Price (ASP), (US$/Ton) & (2018-2029)
Figure 8. By Consumption Value, China Complicated Skin and Skin Structure Infections Drugs Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Complicated Skin and Skin Structure Infections Drugs Market Share of Global, 2018-2029
Figure 10. Global Complicated Skin and Skin Structure Infections Drugs Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Complicated Skin and Skin Structure Infections Drugs Key Participants, Market Share, 2022
Figure 12. Global Complicated Skin and Skin Structure Infections Drugs Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Complicated Skin and Skin Structure Infections Drugs Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Complicated Skin and Skin Structure Infections Drugs Production Market Share & Forecast by Region, 2018-2029
Figure 15. Complicated Skin and Skin Structure Infections Drugs Industry Chain
Figure 16. Complicated Skin and Skin Structure Infections Drugs Procurement Model
Figure 17. Complicated Skin and Skin Structure Infections Drugs Sales Model
Figure 18. Complicated Skin and Skin Structure Infections Drugs Sales Channels, Direct Sales, and Distribution
Figure 19. Tedizolid
Figure 20. Vancomycin
Figure 21. Ceftaroline
Figure 22. Linezolid
Figure 23. Darbavansing
Figure 24. Olivanstar
Figure 25. Tedizolid
Figure 26. By Type, Global Complicated Skin and Skin Structure Infections Drugs Consumption Value, 2018-2029, US$ Million
Figure 27. By Type, Global Complicated Skin and Skin Structure Infections Drugs Consumption Value Market Share, 2018-2029
Figure 28. By Type, Global Complicated Skin and Skin Structure Infections Drugs Sales Quantity, 2018-2029, (Tons)
Figure 29. By Type, Global Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2018-2029
Figure 30. By Type, Global Complicated Skin and Skin Structure Infections Drugs Average Selling Price (ASP), 2018-2029, (US$/Ton)
Figure 31. Hospital
Figure 32. Specialist Clinic
Figure 33. Home Care
Figure 34. Other
Figure 35. By Application, Global Complicated Skin and Skin Structure Infections Drugs Consumption Value, 2018-2029, US$ Million
Figure 36. By Application, Global Complicated Skin and Skin Structure Infections Drugs Consumption Value Market Share, 2018-2029
Figure 37. By Application, Global Complicated Skin and Skin Structure Infections Drugs Sales Quantity, 2018-2029, (Tons)
Figure 38. By Application, Global Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2018-2029
Figure 39. By Application, Global Complicated Skin and Skin Structure Infections Drugs Average Selling Price (ASP), 2018-2029, (US$/Ton)
Figure 40. By Region, Global Complicated Skin and Skin Structure Infections Drugs Consumption Value Market Share, 2018-2029
Figure 41. By Region, Global Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2018-2029
Figure 42. North America Complicated Skin and Skin Structure Infections Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, North America Complicated Skin and Skin Structure Infections Drugs Consumption Value Market Share, 2022
Figure 44. Europe Complicated Skin and Skin Structure Infections Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, Europe Complicated Skin and Skin Structure Infections Drugs Consumption Value Market Share, 2022
Figure 46. Asia Pacific Complicated Skin and Skin Structure Infections Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 47. By Country/Region, Asia Pacific Complicated Skin and Skin Structure Infections Drugs Consumption Value Market Share, 2022
Figure 48. South America Complicated Skin and Skin Structure Infections Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 49. By Country, South America Complicated Skin and Skin Structure Infections Drugs Consumption Value Market Share, 2022
Figure 50. Middle East & Africa Complicated Skin and Skin Structure Infections Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 51. U.S. Complicated Skin and Skin Structure Infections Drugs Sales Quantity, 2018-2029, (Tons)
Figure 52. By Type, U.S. Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, U.S. Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 54. Europe Complicated Skin and Skin Structure Infections Drugs Sales Quantity, 2018-2029, (Tons)
Figure 55. By Type, Europe Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, Europe Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 57. China Complicated Skin and Skin Structure Infections Drugs Sales Quantity, 2018-2029, (Tons)
Figure 58. By Type, China Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, China Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 60. Japan Complicated Skin and Skin Structure Infections Drugs Sales Quantity, 2018-2029, (Tons)
Figure 61. By Type, Japan Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, Japan Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 63. South Korea Complicated Skin and Skin Structure Infections Drugs Sales Quantity, 2018-2029, (Tons)
Figure 64. By Type, South Korea Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, South Korea Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 66. Southeast Asia Complicated Skin and Skin Structure Infections Drugs Sales Quantity, 2018-2029, (Tons)
Figure 67. By Type, Southeast Asia Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, Southeast Asia Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 69. India Complicated Skin and Skin Structure Infections Drugs Sales Quantity, 2018-2029, (Tons)
Figure 70. By Type, India Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 71. By Application, India Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 72. Middle East & Africa Complicated Skin and Skin Structure Infections Drugs Sales Quantity, 2018-2029, (Tons)
Figure 73. By Type, Middle East & Africa Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 74. By Application, Middle East & Africa Complicated Skin and Skin Structure Infections Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 75. Research Methodology
Figure 76. Breakdown of Primary Interviews
Figure 77. Bottom-up and Top-down Approaches
Figure 78. Top-down Approaches
Reason to Buy
- Current and future of Chemical & Material Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Chemical & Material Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Chemical & Material Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Chemical & Material Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets